DeutschNewstral
Article
bizjournals.com on 2015-02-12 16:22
Genetic testing firm Invitae tops IPO targets, raises $102M
Related news
- CBiz Break: S.F. genetic-testing firm Invitae passes IPO test, gains in debutcontracostatimes.com
- Genetic testing firm Invitae seeks IPO of $86 million (Video)bizjournals.com
SoftBank to Lead $1.2 Billion Investment in Genetic-Testing Company Invitaewsj.com- SurveyMonkey tops targets in upsized IPO, raises $180Mbizjournals.com
- 2 more Bay Area life science IPOs coming this week, Invitae sets terms for next weekbizjournals.com
- Christ Hospital, Invitae partner to offer genetic testing to patientsbizjournals.com
- San Francisco surgical lighting developer targets $69M IPObizjournals.com
- MSean George, CEO of Invitae, on the way forward for genetic testing and healthcaremvtelegraph.com
- Another Bay Area life science company targets IPO, hopes to raise $115Mbizjournals.com
- 'Social financing' startup expands loan offerings, targets millennials as it prepares IPObizjournals.com
OraSure inks deal with genetic testing companymcall.com- BThe facts behind DIY genetic testing kitsbadgeronline.co.uk
Ask Amy: Genetic testing reveals family secretSan Jose Mercury News
Genetic-testing scam targets seniors and rips off Medicarelasvegassun.com- GoDaddy tops targets with $440M IPObizjournals.com
- Redwood City biotech boosts IPO targets, hopes to raise up to $184Mbizjournals.com
Employees Jump at Genetic Testing. Is That a Good Thing?The New York Times- The Funded: 2 Bay Area companies boost IPO targets, 7 others raise over $130Mbizjournals.com
Invitae: Q1 Earnings Snapshotbradenton.com